Wiener H L, Thalody G P
Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John's University, Jamaica, NY 11439.
Eur J Pharmacol. 1993 Jul 6;238(1):65-74. doi: 10.1016/0014-2999(93)90506-d.
Previous studies in our laboratory (Wiener et al., 1991, Soc. Neurosci. Abstr. 17, 989) have addressed aspects of the functional antagonism between the responses mediated by activated adenosine A2 receptors and alpha 1-adrenoceptors in adventitia- and endothelium-denuded rabbit thoracic aortic rings by steady-state protocols which ignore the time course of response generation. In the present communication we describe aspects of the time-dependent kinetics of relaxation responses to adenosine A2 receptor agonists in tissues pre-contracted with the alpha 1-adrenoceptor agonist phenylephrine. The results were analyzed by application of the model originally developed by Keitz et al. (1990, J. Pharmacol. Exp. Ther. 255, 650) to describe the relaxation response, to a beta-adrenoceptor agonist, as a first-order exponential decrease in tissue tension over time to estimate the apparent rate constant for relaxation (krel) and the magnitude of relaxation at equilibrium. The magnitude of the relaxation responses to adenosine, N6-cyclohexyladenosine, N6-methyladenosine, 5'-N-ethylcarboxamidoadenosine, and R(-)-N6-(2-phenylisopropyl)adenosine were agonist concentration-dependent and saturable, as were the apparent rate constants for relaxation. In addition, the magnitude of the apparent rate constants for relaxation and the relaxation responses were inversely proportional to the fractional occupancy of the alpha 1-adrenoceptor. The hypothesis put forth by Keitz et al. that the maximal value of the apparent rate constant for relaxation may serve as the kinetic definition of agonist efficacy was also tested and found to be invalid for the adenosine A2 receptor. We propose that this pair of activated receptors and tissue preparation is a good model to study quantitative aspects of functional antagonism by kinetic paradigms.
我们实验室之前的研究(Wiener等人,1991年,《社会神经科学摘要》17卷,989页)通过忽略反应产生时间进程的稳态方案,探讨了活化的腺苷A2受体和α1 -肾上腺素能受体介导的反应在去外膜和内皮的兔胸主动脉环中的功能拮抗方面。在本通讯中,我们描述了用α1 -肾上腺素能受体激动剂去氧肾上腺素预收缩的组织中,对腺苷A2受体激动剂的舒张反应的时间依赖性动力学方面。通过应用Keitz等人(1990年,《药理学与实验治疗学杂志》255卷,650页)最初开发的模型来分析结果,该模型将对β -肾上腺素能受体激动剂的舒张反应描述为组织张力随时间呈一级指数下降,以估计舒张的表观速率常数(krel)和平衡时的舒张幅度。对腺苷、N6 -环己基腺苷、N6 -甲基腺苷、5'-N -乙基羧酰胺腺苷和R(-)-N6-(2 -苯异丙基)腺苷的舒张反应幅度呈激动剂浓度依赖性且可饱和,舒张的表观速率常数也是如此。此外,舒张的表观速率常数幅度和舒张反应与α1 -肾上腺素能受体的占有率成反比。Keitz等人提出的舒张表观速率常数的最大值可作为激动剂效力动力学定义的假设也经过了测试,发现对腺苷A2受体无效。我们提出,这对活化受体和组织制备是通过动力学范式研究功能拮抗定量方面的良好模型。